Founded in 2012, Accellta specializes in 3D suspension culture technology for scalable cell growth without microcarriers or scaffolds. Our innovative platform serves biopharma, biotech, and food-tech industries, enabling cost-effective production of cells for applications like cultured milk fat and regenerative medicine. With over a decade of expertise and a focus on sustainability, Accellta empowers companies to meet large-scale production needs efficiently and reliably.